| Literature DB >> 23587445 |
Erika Parmentier-Decrucq1, Julien Poissy, Raphaël Favory, Saad Nseir, Thierry Onimus, Mary-Jane Guerry, Alain Durocher, Daniel Mathieu.
Abstract
BACKGROUND: Transport of critically ill patients for diagnostic or therapeutic procedures is at risk of complications. Adverse events during transport are common and may have significant consequences for the patient. The objective of the study was to collect prospectively adverse events that occurred during intrahospital transports of critically ill patients and to determine their risk factors.Entities:
Year: 2013 PMID: 23587445 PMCID: PMC3639083 DOI: 10.1186/2110-5820-3-10
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Figure 1Flowchart.
Global characteristics of patients
| | | | | |
| Age (yr) | 58 | [48–71] | | |
| Man | | | 129 | 70.1 |
| SAPS II | 48 | [34–62] | | |
| COPD | | | 26 | 14 |
| ALI | | | 125 | 68 |
| ARDS | | | 56 | 30.4 |
| | | | | |
| Length of stay in ICU (days) | 16 | [8.25-25.75] | | |
| Length of mechanical ventilation (days) | 11 | [6–21.75] | | |
| Dialysis during hospitalization | | | 48 | 26 |
| Ventilator-associated pneumonia | | | 56 | 30.4 |
| Death Day 28 | | | 55 | 29.9 |
| Death in ICU | 69 | 37.5 |
SAPS II = Simplified Acute Physiology Score II; COPD = chronic obstructive pulmonary disease; ALI = acute lung injury; ARDS = acute respiratory distress syndrome.
Characteristics of patients before and during IHT
| | | | | |
| | [ | | | |
| | | | ||
| Orotracheal tube | | | 169 | 64.5 |
| Nasotracheal tube | | | 64 | 24.4 |
| Tracheotomy | | | 29 | 11.1 |
| | | | ||
| Subclavian vein | | | 148 | 56.5 |
| Internal jugular vein | | | 23 | 8.8 |
| Femoral vein | | | 49 | 18.7 |
| | | |||
| Radial | | | 159 | 60.7 |
| Femoral | | | 38 | 14.5 |
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | | |
| VAC | | | 214 | 81.7 |
| BIPAP | | | 18 | 6.9 |
| PSV | | | 27 | 10.7 |
| | | | ||
| | [ | | | |
| | | | | |
| Sedation | | | 153 | 58.4 |
| Neuromuscular blocker | | | 27 | 10.3 |
| Norepinephrine | | | 45 | 17.2 |
| Dobutamine | | | 32 | 12.2 |
| Epinephrine | | | 4 | 1.5 |
| | | | | |
| | [ | | | |
| | | | ||
| | | | ||
| | | | | |
| VAC | | | 249 | 95.0 |
| PSV | | | 13 | 5.0 |
| | | | | |
| Ventilatory mode change for transport | | | 35 | 13.4 |
| FiO2 during IHT (%) | 100 | [50–100] | | |
| PEEP during IHT (cmH2O) | 6 | [ | | |
| Change of PEEP for transport | | | 23 | 8.8 |
| | | | ||
| Sedation for transport | | | 38 | 14.5 |
| Neuromuscular blocker use for transport | | | 16 | 6.1 |
| Fluid challenge for transport | | | 12 | 4.6 |
| | | | | |
| Junior physician with experience | | | 144 | 60 |
| Junior anesthetist physician | 121 | 50.4 |
SOFA = Sepsis-related Organ Failure Assessment; SAPS II = Simplified Acute Physiology Score II; IHT = intrahospital transport; VAC = volume assist–control; BIPAP = bi-level positive airway pressure; PSV = pressure support ventilation; FiO2 = fraction of inspired oxygen; PEEP = positive end-expiratory pressure.
Adverse events during transport
| | ||
| Oxygen desaturation | 23 | 8.8 |
| Extubation | 1 | 0.4 |
| Accidental central venous catheter removal | 1 | 0.4 |
| Hemodynamic instability | 13 | 5 |
| Increased vasopressor dose | 5 | 1.9 |
| | ||
| Agitation | 38 | 14.5 |
| Accidental nasogastric tube pull out | 1 | 0.4 |
| Vomiting | 3 | 1.1 |
| Peripheral venous catheter incident | 4 | 1.5 |
| Central venous catheter incident | 6 | 2.3 |
| Arterial line incident | 5 | 1.9 |
| Accidental dislodging of urinary catheter | 1 | 0.4 |
| Disconnection of endotracheal tube and airway equipment | 2 | 0.8 |
| Incident with airway equipment (alarm, adjustment) | 46 | 17.6 |
| Incident with monitor (battery, alarm) | 45 | 17.2 |
| Incident with infusion pumps (battery, alarm) | 18 | 6.9 |
Risk factors of adverse events during IHT
| | | | | |
| Dialysis | 0.76 (0.44-1.32) | NS | | |
| Sedation | 2.02 (1.22-3.34) | 0.008 | 1.85 (1.1-3.11) | 0.021 |
| Neuromuscular blockers use | 1.55 (0.69-3.45) | NS | | |
| Norepinephrine before transport | 1.61 (0.84-3.06) | NS | | |
| Dobutamine before transport | 1.21 (0.58-2.54) | NS | | |
| | | | | |
| VAC | 0.9 (0.48-1.69) | NS | | |
| BIPAP | 0.94 (0.36-2.47) | NS | | |
| PSV | 1.42 (0.65-3.11) | NS | | |
| FiO2 before IHT >60% | 1.51 (0.81-2.83) | NS | | |
| PEEP before IHT >6 cmH2O | 2.27 (1.34-3.85) | 0.003 | 2.28 (1.32-3.95) | 0.003 |
| | | | | |
| More than four infusion pumps for transport | 3.4 (0.88-13.03) | 0.071 | | NS |
| Ventilatory mode change for transport | 1.3 (0.64-2.65) | NS | | |
| Change of PEEP for transport | 0.84 (0.05-13.64) | NS | | |
| Treatment modification for transport | 2.22 (1.23-4.01) | 0.011 | | NS |
| Sedation for transport | 1.77 (0.88-3.55) | NS | | |
| Neuromuscular blocker use for transport | 1.2 (0.44-3.29) | NS | | |
| Fluid challenge for transport | 6.36 (1.37-29.64) | 0.014 | 6.48 (1.32-31.69) | 0.021 |
| | | |||
| | ||||
| | | | | |
| Age (yr) | 61 (44–74) | 58 (50.5-68) | NS | |
| SAPS II | 48 (34–61) | 48 (34–64) | NS | |
| | | | | |
| SOFA the day of transport | 5 [ | 5 [ | NS | |
| MV duration before transport (days) | 4 [2–11.25] | 4 [2–10.75] | NS | |
| No. of infusion pumps during transport | 2 [ | 3 [ | p = 0.015 | NS |
VAC = volume assist–control; BIPAP = bi-level positive airway pressure; PSV = pressure support ventilation; FiO = fraction of inspired oxygen; PEEP = positive end-expiratory pressure; SOFA = Sepsis-related Organ Failure Assessment; SAPS II = Simplified Acute Physiology Score; MV = mechanical ventilation; OR = odds ratio; CI = confidence interval.
Risk factors of patient-related adverse events during IHT
| | | | | |
| Dialysis | 0.84 (0.45-1.58) | NS | | |
| Sedation | 1.48 (0.83-2.61) | NS | | |
| Neuromuscular blockers use | 0.78 (0.3-2.02) | NS | | |
| Norepinephrine before transport | 1.71 (0.86-3.39) | NS | | |
| Dobutamine before transport | 1.11 (0.49-2.53) | NS | | |
| | | | | |
| VAC | 1.09 (0.53-2.24) | NS | | |
| BIPAP | 1.44 (0.52-3.99) | NS | | |
| PSV | 0.74 (0.29-1.91) | NS | | |
| FiO2 before IHT > 60% | 1.52 (0.77-2.99) | NS | | |
| PEEP before IHT > 6 cmH2O | 2.16 (1.22-3.81) | 0.01 | 2.11 (1.17-3.8) | 0.01 |
| | | | | |
| More than four infusion pumps for transport | 1.07 (0.28-4.17) | NS | | |
| Ventilatory mode change for transport | 1.14 (0.52-2.51) | NS | | |
| Change of PEEP for transport | 0.76 (0.27-2.13) | NS | | |
| Treatment modification for transport | 2.66 (1.44-4.91) | 0.002 | 2.81 (1.5-5.3) | 0.001 |
| Sedation for transport | 3.05 (1.5-6.21) | 0.003 | | NS |
| Neuromuscular blocker use for transport | 0.93 (0.29-2.98) | NS | | |
| Fluid challenge for transport | 2.97 (0.92-9.54) | 0.087 | | NS |
| | | | ||
| Age (yr) | 57.5 [46–71.25] | 59.5 [50.75-69.5] | NS | |
| SAPS II | 47 [34–61.5] | 49 [34–64] | NS | |
| | | | ||
| SOFA the day of transport | 5 [ | 5 [3–8.75] | NS | |
| MV duration before transport (days) | 4.5 [2–12.25] | 3.5 [2–9.75] | NS | |
| No. of infusion pumps during transport | 2 [ | 2 [ | NS | |
VAC = volume assist–control; BIPAP = bi-level positive airway pressure; PSV = pressure support ventilation; FiO = fraction of inspired oxygen; PEEP = positive end-expiratory pressure; SOFA = Sepsis-related Organ Failure Assessment; SAPS II = Simplified Acute Physiology Score; MV = mechanical ventilation; SD = standard deviation; OR = odds ratio; CI = confidence interval; NS = not significant.